111 related articles for article (PubMed ID: 32735728)
21. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
Yang C; Gong A
Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
[No Abstract] [Full Text] [Related]
22. Enzyme replacement therapy attenuates disease progression in a canine model of late-infantile neuronal ceroid lipofuscinosis (CLN2 disease).
Katz ML; Coates JR; Sibigtroth CM; Taylor JD; Carpentier M; Young WM; Wininger FA; Kennedy D; Vuillemenot BR; O'Neill CA
J Neurosci Res; 2014 Nov; 92(11):1591-8. PubMed ID: 24938720
[TBL] [Abstract][Full Text] [Related]
23. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
[TBL] [Abstract][Full Text] [Related]
24. Lysosomal enzyme tripeptidyl peptidase 1 destabilizes fibrillar Aβ by multiple endoproteolytic cleavages within the β-sheet domain.
Solé-Domènech S; Rojas AV; Maisuradze GG; Scheraga HA; Lobel P; Maxfield FR
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1493-1498. PubMed ID: 29378960
[TBL] [Abstract][Full Text] [Related]
25. Functional consequences and rescue potential of pathogenic missense mutations in tripeptidyl peptidase I.
Walus M; Kida E; Golabek AA
Hum Mutat; 2010 Jun; 31(6):710-21. PubMed ID: 20340139
[TBL] [Abstract][Full Text] [Related]
26. Neurofilament light is a treatment-responsive biomarker in CLN2 disease.
Ru Y; Corado C; Soon RK; Melton AC; Harris A; Yu GK; Pryer N; Sinclair JR; Katz ML; Ajayi T; Jacoby D; Russell CB; Chandriani S
Ann Clin Transl Neurol; 2019 Dec; 6(12):2437-2447. PubMed ID: 31814335
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis of neuronal ceroid lipofuscinosis type 2 (CLN2 disease): Expert recommendations for early detection and laboratory diagnosis.
Fietz M; AlSayed M; Burke D; Cohen-Pfeffer J; Cooper JD; Dvořáková L; Giugliani R; Izzo E; Jahnová H; Lukacs Z; Mole SE; Noher de Halac I; Pearce DA; Poupetova H; Schulz A; Specchio N; Xin W; Miller N
Mol Genet Metab; 2016 Sep; 119(1-2):160-7. PubMed ID: 27553878
[TBL] [Abstract][Full Text] [Related]
28. A Basic ApoE-Based Peptide Mediator to Deliver Proteins across the Blood-Brain Barrier: Long-Term Efficacy, Toxicity, and Mechanism.
Meng Y; Wiseman JA; Nemtsova Y; Moore DF; Guevarra J; Reuhl K; Banks WA; Daneman R; Sleat DE; Lobel P
Mol Ther; 2017 Jul; 25(7):1531-1543. PubMed ID: 28456380
[TBL] [Abstract][Full Text] [Related]
29. MYO5B is epigenetically silenced and associated with MET signaling in human gastric cancer.
Dong W; Wang L; Shen R
Dig Dis Sci; 2013 Jul; 58(7):2038-45. PubMed ID: 23456500
[TBL] [Abstract][Full Text] [Related]
30. Identification of functional lncRNAs in gastric cancer by integrative analysis of GEO and TCGA data.
Zhang X; Zhang W; Jiang Y; Liu K; Ran L; Song F
J Cell Biochem; 2019 Oct; 120(10):17898-17911. PubMed ID: 31135068
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological significance of NMIIA overexpression in human gastric cancer.
Liu D; Zhang L; Shen Z; Tan F; Hu Y; Yu J; Li G
Int J Mol Sci; 2012 Nov; 13(11):15291-304. PubMed ID: 23203126
[TBL] [Abstract][Full Text] [Related]
32. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
[TBL] [Abstract][Full Text] [Related]
33. An integrated strategy for the diagnosis of neuronal ceroid lipofuscinosis types 1 (CLN1) and 2 (CLN2) in eleven Latin American patients.
Kohan R; Cismondi IA; Kremer RD; Muller VJ; Guelbert N; Anzolini VT; Fietz MJ; Ramírez AM; Halac IN
Clin Genet; 2009 Oct; 76(4):372-82. PubMed ID: 19793312
[TBL] [Abstract][Full Text] [Related]
34. Untargeted Metabolite Profiling of Cerebrospinal Fluid Uncovers Biomarkers for Severity of Late Infantile Neuronal Ceroid Lipofuscinosis (CLN2, Batten Disease).
Sindelar M; Dyke JP; Deeb RS; Sondhi D; Kaminsky SM; Kosofsky BE; Ballon DJ; Crystal RG; Gross SS
Sci Rep; 2018 Oct; 8(1):15229. PubMed ID: 30323181
[TBL] [Abstract][Full Text] [Related]
35. CD40 DNA hypermethylation in primary gastric tumors; as a novel diagnostic biomarker.
Amini M; Ghorban K; Mokhtarzadeh A; Dadmanesh M; Baradaran B
Life Sci; 2020 Aug; 254():117774. PubMed ID: 32407843
[TBL] [Abstract][Full Text] [Related]
36. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
Zhang C; Zhang CD; Ma MH; Dai DQ
World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
[TBL] [Abstract][Full Text] [Related]
37. THBS4 predicts poor outcomes and promotes proliferation and metastasis in gastric cancer.
Chen X; Huang Y; Wang Y; Wu Q; Hong S; Huang Z
J Physiol Biochem; 2019 Feb; 75(1):117-123. PubMed ID: 30746617
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of PURPL and downregulation of NONHSAT062994 as potential biomarkers in gastric cancer.
Moridi H; Karimi J; Tavilani H; Khodadadi I; Emami Razavi AN
Life Sci; 2019 Nov; 237():116904. PubMed ID: 31606380
[TBL] [Abstract][Full Text] [Related]
39. MYO5B mutations in pheochromocytoma/paraganglioma promote cancer progression.
Tomić TT; Olausson J; Rehammar A; Deland L; Muth A; Ejeskär K; Nilsson S; Kristiansson E; Wassén ON; Abel F
PLoS Genet; 2020 Jun; 16(6):e1008803. PubMed ID: 32511227
[TBL] [Abstract][Full Text] [Related]
40. Different molecular mechanisms involved in spontaneous and oxidative stress-induced mitochondrial fragmentation in tripeptidyl peptidase-1 (TPP-1)-deficient fibroblasts.
Van Beersel G; Tihon E; Demine S; Hamer I; Jadot M; Arnould T
Biosci Rep; 2013 Feb; 33(2):e00023. PubMed ID: 23249249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]